| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-05 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.13 | 2e-05 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | 0.13 | 3e-05 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | 0.14 | 3e-05 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.22 | 3e-05 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.14 | 4e-05 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.14 | 5e-05 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.14 | 6e-05 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | 0.14 | 7e-05 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | -0.14 | 9e-05 |